Thermodynamic Assessment of Triclocarban Dissolution Process in N-Methyl-2-pyrrolidone + Water Cosolvent Mixtures
- PMID: 37894697
- PMCID: PMC10609577
- DOI: 10.3390/molecules28207216
Thermodynamic Assessment of Triclocarban Dissolution Process in N-Methyl-2-pyrrolidone + Water Cosolvent Mixtures
Abstract
Solubility is one of the most important physicochemical properties due to its involvement in physiological (bioavailability), industrial (design) and environmental (biotoxicity) processes, and in this regard, cosolvency is one of the best strategies to increase the solubility of poorly soluble drugs in aqueous systems. Thus, the aim of this research is to thermodynamically evaluate the dissolution process of triclocarban (TCC) in cosolvent mixtures of {N-methyl-2-pyrrolidone (NMP) + water (W)} at seven temperatures (288.15, 293.15, 298.15, 303.15, 308.15, 313.15 and 318.15 K). Solubility is determined by UV/vis spectrophotometry using the flask-shaking method. The dissolution process of the TCC is endothermic and strongly dependent on the cosolvent composition, achieving the minimum solubility in pure water and the maximum solubility in NMP. The activity coefficient decreases from pure water to NMP, reaching values less than one, demonstrating the excellent positive cosolvent effect of NMP, which is corroborated by the negative values of the Gibbs energy of transfer. In general terms, the dissolution process is endothermic, and the increase in TCC solubility may be due to the affinity of TCC with NMP, in addition to the water de-structuring capacity of NMP generating a higher number of free water molecules.
Keywords: N-methyl-2-pyrrolidone; cosolvent; modeling; simulation; solubility; thermodynamics; triclocarban; water.
Conflict of interest statement
The authors declare no conflict of interest.
Figures
References
-
- Zhang Y., He L., Yang Y., Cao J., Su Z., Zhang B., Guo H., Wang Z., Zhang P., Xie J., et al. Triclocarban triggers osteoarthritis via DNMT1-mediated epigenetic modification and suppression of COL2A in cartilage tissues. J. Hazard. Mater. 2023;447:130747. doi: 10.1016/j.jhazmat.2023.130747. - DOI - PubMed
-
- FDA U.S. Safety and Effectiveness of Consumer Antiseptics; Topical Antimicrobial Drug Products for Over-the-Counter Human Use-Final Rule. FDA; Silver Spring, MD, USA: 2016. (21 CFR Part 310 Docket No. Technical Report). - PubMed
-
- Commission E. Commission Implementing decision (EU) 2016/110 of 27 January 2016 Not Approving Triclosan as an Existing Active Substance for Use in Biocidal Products for Product-Type 1. European Commission; Brussels, Belgium: 2016. (Technical Report).
LinkOut - more resources
Full Text Sources
